Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study

References

• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 Lyon, France: International Agency for Research on Cancer, 2013. Available from http://globocan.iarc.fr
   Google Scholar
• Van Schil PE. Surgery for non-small cell lung cancer. Lung Cancer 2001;34(Suppl2):S127–32
   PubMed Web of Science ®Google Scholar
• El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg 2006;82:408–15; discussion 15–16
   PubMed Web of Science ®Google Scholar
• Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001;2:CD002935
   PubMedGoogle Scholar
• Abbas G, Schuchert MJ, Pennathur A, Gilbert S, Luketich JD. Ablative treatments for lung tumors: Radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 2007;17:261–71
   PubMedGoogle Scholar
• O’Rourke N, Roque IFM, Farre Bernado N, Macbeth F. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2010;6:CD002140
   PubMed Web of Science ®Google Scholar
• Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352–8
   PubMed Web of Science ®Google Scholar
• Sura S, Gupta V, Yorke E, Jackson A, Amols H, Rosenzweig KE. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol 2008;87:17–23
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47
   PubMed Web of Science ®Google Scholar
• US National Caner Institute. Common terminology criteria for adverse events (CTCAE) version 4.03. US Depatment of Health and Human Services, 2010, revised 2014. Available from http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
   Google Scholar
• Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH, et al. Recurrent non-small cell lung cancer: Evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol 2012;53:893–9
   PubMed Web of Science ®Google Scholar
• Leung VA, DiPetrillo TA, Dupuy DE. Image-guided tumor ablation for the treatment of recurrent non-small cell lung cancer within the radiation field. Eur J Radiol 2011;80:e491–9
   PubMed Web of Science ®Google Scholar
• Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, et al. Pulmonary radiofrequency ablation: Long-term safety and efficacy in 153 patients. Radiology 2007;243:268–75
   PubMed Web of Science ®Google Scholar
• Choe YH, Kim SR, Lee KS, Lee KY, Park SJ, Jin GY, et al. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Eur J Cancer 2009;45:1773–9
   PubMed Web of Science ®Google Scholar
• Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: Results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007;134:1306–12
   PubMed Web of Science ®Google Scholar
• Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007;134:857–64
   PubMed Web of Science ®Google Scholar
• Hiraki T, Mimura H, Gobara H, Sano Y, Fujiwara H, Date H, et al. Repeat radiofrequency ablation for local progression of lung tumors: Does it have a role in local tumor control? J Vasc Intervent Radiol 2008;19:706–11
   PubMed Web of Science ®Google Scholar
• Hiraki T, Tajiri N, Mimura H, Yasui K, Gobara H, Mukai T, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: Incidence and risk factors. Radiology 2006;241:275–83
   PubMed Web of Science ®Google Scholar
• Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, Wain JC, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:160–6
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, et al. Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621–8
   PubMed Web of Science ®Google Scholar
• Acksteiner C, Steinke K. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: A promising outlook. J Med Imaging Radiat Oncol 2015;59:82–90
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Mangini M, Fontana F, Di Massa A, Ierardi AM, Cotta E, et al. Complications of microwave and radiofrequency lung ablation: Personal experience and review of the literature. Radiologia Medica 2012;117:201–13
   PubMed Web of Science ®Google Scholar
• Jahangeer S, Forde P, Soden D, Hinchion J. Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours. Cancer Treat Rev 2013;39:862–71
   PubMed Web of Science ®Google Scholar
• Little MW, Chung D, Boardman P, Gleeson FV, Anderson EM. Microwave ablation of pulmonary malignancies using a novel high-energy antenna system. Cardiovasc Intervent Radiol 2013;36:460–5
   PubMed Web of Science ®Google Scholar
• Lu Q, Cao W, Huang L, Wan Y, Liu T, Cheng Q, et al. CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases. World J Surg Oncol 2012;10:80
   PubMed Web of Science ®Google Scholar
• Splatt AM, Steinke K. Major complications of high-energy microwave ablation for percutaneous CT-guided treatment of lung malignancies: Single-centre experience after 4 years. J Med Imaging Radiat Oncol 2015;59:609–16
   PubMed Web of Science ®Google Scholar
• Steinke K, Liu H. Minimally invasive techniques for medically inoperable stage I non-small cell lung cancer (NSCLC) – image-guided microwave ablation, a promising therapy option. J Med Imaging Radiat Oncol 2014;58:79–80
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: Clinical utility in treatment of pulmonary metastases. Radiology 2011;261:643–51
   PubMed Web of Science ®Google Scholar
• Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: Principles and applications. Radiographics 2005;25:S69–83
   PubMed Web of Science ®Google Scholar
• Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DS. Microwave liver ablation: Influence of hepatic vein size on heat-sink effect in a porcine model. J VascI Intervent Radiol 2008;19:1087–92
   PubMed Web of Science ®Google Scholar
• Durick NA, Laeseke PF, Broderick LS, Lee FT, Jr, Sampson LA, Frey TM, et al. Microwave ablation with triaxial antennas tuned for lung: Results in an in vivo porcine model. Radiology 2008;247:80–7
   PubMed Web of Science ®Google Scholar
• Shirvani SM, Chang JY, Roth JA. Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery? Thorac Surg Clin 2013;23:369–81
   PubMed Web of Science ®Google Scholar
• Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(Suppl5):e278–313
   Web of Science ®Google Scholar
• Dupuy DE, DiPetrillo T, Gandhi S, Ready N, Ng T, Donat W, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006;129:738–45
   PubMed Web of Science ®Google Scholar
• Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: Outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Intervent Radiol 2006;17:1117–24
   PubMed Web of Science ®Google Scholar
• Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction. Clin Cancer Res 2003;9:1957–71
   PubMed Web of Science ®Google Scholar
• Jain SK, Dupuy DE, Cardarelli GA, Zheng Z, DiPetrillo TA. Percutaneous radiofrequency ablation of pulmonary malignancies: Combined treatment with brachytherapy. Am J Roentgenol 2003;181:711–15
   PubMed Web of Science ®Google Scholar
• Kosterev VV, Kramer-Ageev EA, Mazokhin VN, van Rhoon GC, Crezee J. Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating. Int J Hyperthermia 2015;31:443–52
   PubMed Web of Science ®Google Scholar